2018 NDARC Annual Research Symposium

image - 2018 Symposium Banner

NDARC's Annual Research Symposium will take place on Monday, 8 October 2018. This year, the Symposium will explore clinical, community and policy responses to emerging problems in drug and alcohol use.

Registration for the 2018 NDARC Annual Research Symposium is now open. Please click here to register

The Symposium's key topics include:

  • Embedding evaluation into the delivery of routine services
  • Emerging trends in drug use, harms, and markets: Findings from Drug Trends 2018
  • Treatment within prison settings
  • Working with Aboriginal communities
  • Working with NGOs
  • Criminal justice responses
  • Eliminating HCV among people who inject drugs
  • Long-acting buprenorphine for the treatment of opioid dependence
  • The impact of OST on reducing crime among opioid dependent people
Program: 

Click here to download the program (PDF)

8.30 – 9.00am Registration
9.00 – 9.10am Acknowledgement of Country
9.10 – 9.15am Welcome
Professor Rodney Phillips
Dean, UNSW Medicine

Plenary One Session Chair: Mr Chris Killick-Moran
Alcohol, Tobacco and Other Drugs Branch, Australian Government Department of Health

9.15 – 10.00am Keynote Address:
Embedding evaluation and learning into the delivery of routine services
Professor Louis Fiore
Professor of Medicine and Professor Epidemiology
Boston University School of Public Health, VA Boston Healthcare System
10.00 – 10.20am Harnessing clinical informatics to transform clinical research: An overview of the NSW AoD Clinical Outcomes and Quality Indicators system
Conjoint Professor Nicholas Lintzeris
Director Drug and Alcohol Services, South Eastern Sydney Local Health District
10.20 – 10.40am The development and testing of a framework to increase the uptake of integrated care into routine service delivery by drug and alcohol and mental health clinical services
Ms Catherine Foley
Doctoral Candidate, NDARC
10.40 -10.50am

Two minute poster presentations
Chair: Dr Sarah Larney
Poster Presenters: Sonja Memedovic, Richard Mellor, Natasa Gisev, Janni Leung, Samantha Colledge

10.50 -11.10am Morning Tea

Plenary Two Drug Trends Session Chair: Mr Daniel Madeddu
Centre for Population Health, NSW Health

11.10 – 11.30am Emerging trends in drug use, harms, and markets: Findings from Drug Trends 2018
Dr Amy Peacock
NHMRC Early Career Research Fellow, NDARC
11.30 – 11.50am Availability and use of new and emerging psychoactive substances in Australia: Findings from Drug Trends 2018
Ms Rachel Sutherland
Doctoral Candidate, Senior Research Officer Drug Trends Program, NDARC
11.50 – 12.10pm Trends in fentanyl availability, use and harms Australia: Findings from Drug Trends 2018
Associate Professor Raimondo Bruno
University of Tasmania
12.10 - 12.15pm

Two minute poster presentation
Chair: Dr Sarah Larney
Poster Presenters: Rebecca Bosworth, Michala Kowalksi

12.15 – 13.15pm Breakout Sessions
Breakout One:
Challenges of translating research into policy

Session Chair: Professor Louisa Degenhardt
Translation of research into policy and practice: examples from smoking cessation
Dr Hayden McRobbie
Professor of Public Health Intervention
Queen Mary University of London

Discussion Panel
Ms Jo Mitchell
Executive Director, Centre for Population Health at NSW Health

Professor Michael Farrell
Director, National Drug and Alcohol Research Centre, NDARC

Breakout Two:
Responding to harms: Clinical treatment

Session Chair: Associate Professor Timothy Dobbins
Cytisine versus varenicline for smoking cessation: A single-blind randomised controlled clinical trial
Dr Ryan Courtney
Early Career Research Fellow, Cancer Institute New South Wales
Monthly injections of long-acting buprenorphine for the treatment of opioid dependence
Dr Briony Larance
Senior Research Fellow, University of Wollongong
The effect of treatment and retention in opioid substitution therapy on reducing crime among opioid dependent people
Dr Natasa Gisev
NHMRC Early Career Research Fellow, NDARC
Screening for prescribed opioid dependence in primary care settings
Associate Professor Suzanne Nielsen
Monash University
Breakout Three:
Treatment within prison settings

Session Chair: Dr Marian Shanahan
Surveillance and Treatment of Prisoners with Hepatitis C
Professor Andrew Lloyd
Program Head Viral Immunology Systems Program
The Kirby Institute

Trial of depot buprenorphine in prisons
Professor Adrian Dunlop
Director Drug and Alcohol Services
Hunter New England Local Health District

The SNAP study – A randomised controlled trial of a brief intervention “SNAP” to prevent relapse to smoking after release from smoke-free prisons in the Northern Territory
Professor Kate Dolan
NDARC
Alcohol Treatment within a prison setting
Mr Michael Doyle
Research Fellow at the Centre for Research Excellence (CRE) in Indigenous Health and Alcohol, University of Sydney
Breakout Four:
Prevention: working with Aboriginal communities

Session Chair: Professor Anthony Shakeshaft
Exploring the role of Aboriginal women in their families and communities: it’s impact on their health and implications for delivery of services
Dr Anne-Marie Eades
UNSW Scientia Fellow Faculty of Medicine, UNSW Sydney
Cultures within cultures investigating conflict in Aboriginal communities and its influence on alcohol and drug related harms
Ms Bonita Byrne
Masters by Research Candidate, NDARC
The impact of community-developed responses to alcohol-related harms: demonstrating the value of community/researcher partnerships
Dr Alice Munro and Dr Mieke Snijder
Research Capacity Building Manager
Western NSW LHD and Postdoctoral Researcher
The experience of Aboriginal communities engaging in research
Mr Jamie O'Neill
CEO
Murrin Bridge Aboriginal Lands Council
13.15 – 14.15pm Lunch (and poster viewing)
14.15 – 15.20pm Breakout Sessions
Breakout Five:
Young People, Alcohol and Other Drugs

Session Chair: Dr Amy Peacock
Adverse adult consequences of different alcohol use patterns in adolescence
Mr Philip Clare
Doctoral Candidate and Biostatistician, NDARC
What the APSALS and consortium data tell us about taking a population level approach rather than targeting heavy/binge drinkers
Ms Veronica Boland
Senior Research Officer, NDARC
The effectiveness and cost-benefit of an NGO delivered program for high-risk young people, and integrating research into multiple NGO services nationally
Ms Skye Bullen
Masters by Research Candidate, NDARC
Steroids and harm reduction: working with young adults who use performance and image enhancing drugs (PIEDs)
Dr Katinka Van de Ven
Research Fellow, NDARC
Breakout Six:
Responding to harms: The co-creation of a research agenda with treatment services

Session Chair: Professor Anthony Shakeshaft
Co-creation of new knowledge is at the heart of embedding research into routine service delivery, but what is it and how often is it done?
Ms Tania Pearce
Doctoral Candidate, University of New England
The impact of research on Aboriginal residential rehabilitation services
Mr Joe Coyte
CEO of The Glen Central Coast Drug and Alcohol Rehabilitation Centre
The experience of consumers involved in the co-design and implementation of a model of Integrated Care: A facilitated discussion
Panel discussion
Breakout Seven:
Comorbidity

Session Chair: Professor Louisa Degenhardt
Review of psychiatric consequences of methamphetamine use
Dr Emily Stockings
NHMRC Early Career Research Fellow, NDARC
The impact of comorbid mental health disorders on receipt of substance use disorder treatment
Dr Chrianna Bharat
Research Fellow, NDARC
Psychostimulant use and fatal stroke in young adults: a national study
Professor Shane Darke
NDARC
Breakout Eight:
Criminal Justice Responses

Session Chair: Dr Sarah Larney
Does imprisoning drink-drivers reduce the risk of drink-driving? 
Dr Don Weatherburn
Director of the NSW Bureau of Crime Statistics and Research
Drug-related police encounters across the globe: How does Australia compare?
Dr Caitlin Hughes
Senior Research Fellow, NDARC
Understanding how a high-level drug trafficking network in Australia adapted to changes in its drug supply
Mr Matthew O’Reilly
Doctoral Candidate, NDARC
15.20 – 15.40pm Afternoon Tea
Plenary Three Session Chair: Professor Michael Farrell
15.40 – 16.25pm Enhancing quality health care for people who use drugs
Professor Julie Bruneau
Professor in the Department of Family Medicine, University of Montreal
16.25 – 16.45pm National Centre for Clinical Research Excellence on Emerging Drugs (NCCRED)
Associate Professor Nadine Ezard
Director NCCRED and Clinical Director Drug and Alcohol Services, St Vincent’s Hospital
16.45 – 17.05pm HCV elimination among people who inject drugs: Feasibility and future requirements
Associate Professor Jason Grebely
Senior Research Fellow, The Kirby Institute
17.05 – 17.15pm Discussion and Wrap (Will include announcement of People’s Choice poster winner)
Professor Michael Farrell
Director, NDARC
17.15 – 18.15pm Symposium Drinks

 

Registration: 

Registration for the 2018 NDARC Annual Research Symposium is now open. Please click here to register

Speakers: 

Keynote speakers:

Professor Louis Fiore

Dr Louis Fiore is a Physician-scientist-manager-innovator with board certifications in internal medicine, oncology and hematology. He is a Professor of Epidemiology at the Boston University School of Medicine. Additionally, he is currently the Executive Director of a research group within the Department of Veterans Affairs The Center (MAVERIC) provides the Department nationally with expertise in large scale clinical trials and bioinformatics. Current research and trials are underway.


Dr Hayden McRobbie

image - 2018 NDARC Annual Research Symposium

Hayden McRobbie is Professor in Public Health Interventions at Barts and The London School of Medicine and Dentistry, Queen Mary University of London (UK), Clinical Director of the Dragon Institute for Innovation (NZ) and a Medical Smoking Cessation Specialist at Counties Manukau District Health Board.

After completing his medical degree, he went on to study in London and gained a PhD in medical psychology. He now has over 18 years’ experience in the provision of behaviour change interventions in the fields of smoking cessation and weight management.  Hayden has played a key role in Tobacco Control in New Zealand and is also the Clinical Champion for Child Wellbeing for the New Zealand Ministry of Health.


Dr Julie Bruneau

image - 2018 NDARC Annual Research Symposium

Dr Julie Bruneau is Professor in the Department of Family and Emergency Medicine at Université de Montréal and clinical researcher at the Centre Hospitalier de l’Université de Montréal (CHUM) research center.  She is recognized as a leader in addiction medicine in Canada, and was central in the development of access to integrated care for people who inject drugs, including Opiate Agonist Treatment (OAT) and syringe Distribution Program networks in the province of Quebec.

Over the past 20 years, her research contributed to a better understanding of factors impeding and facilitating harm reduction efforts  to reduce HIV and HCV transmission among persons who inject drugs. Dr Bruneau is the scientific director of the Quebec-Atlantic node of Canadian Research Initiative on Drug Misuse (CRISM), a network conducting a number of trials and implementation science projects to address the opioid crisis and develop better care for people who use drugs in Canada.